peoplePerson
Nina Bhardwaj
Nina Bhardwaj is a dendritic-cell immunologist running personalised neoantigen vaccine trials.
Pioneer of dendritic cell biology in human immunity; leads the PGV001 personalised neoantigen peptide vaccine programme at Mount Sinai.
Role
Director of Immunotherapy; Ward-Coleman Chair in Cancer Research
Specialisms
Dendritic cellsCancer vaccinesPersonalised neoantigen vaccines
Profiles
| Title | Journal | Year |
|---|---|---|
| A phase I trial of the safety and immunogenicity of a multi-peptide personalized genomic vaccine in the adjuvant treatment of solid cancers | Cancer Discovery | 2024 |
Pages like this
not linked directly; found by shared links- CompanySerova
- PersonJoshua Brody
Shares The Mount Sinai Hospital / Tisch Cancer Institute, Off-the-shelf cancer vaccines.
- CompanyGritstone bio
Shares Off-the-shelf cancer vaccines, Personalised neoantigen (mRNA) vaccines.
- IdeaVaccinate against the resistance mutation before it takes over
Shares Off-the-shelf cancer vaccines, Neoantigen, Personalised neoantigen (mRNA) vaccines.
- PersonKellie N. Smith
- PersonYuquan Wei
Shares Off-the-shelf cancer vaccines, Personalised neoantigen (mRNA) vaccines.
- PersonMalachi Griffith
- IdeaA frameshift neoantigen vaccine for Lynch syndrome carriers as the first preventive cancer vaccine approval
Shares Off-the-shelf cancer vaccines, Neoantigen, Personalised neoantigen (mRNA) vaccines.